Abstract
Cancer associated retinopathy (CAR) is an ocular manifestation of paraneoplastic syndrome clinically characterized by progressive visual impairment similar to retinitis pigmentosa. As a possible mechanism causing the retinal degeneration, the presence of serum autoantibodies against recoverin and other retinal antigens are involved. The molecular pathology in CAR by anti-recoverin antibody is considered to occur in the following steps: Firstly, recoverin aberrantly expressed in cancerous tissues is recognized by immunocytes by some unknown mechanisms and then a specific antibody toward recoverin is produced. Secondly, the anti-recoverin antibody reaches the retina via the peripheral circulation and is taken up into photoreceptor cells. Lastly, the antibody blocks recoverin function (inhibition of rhodopsin phosphorylation in a calcium dependent manner), and enhancement of rhodopsin phosphorylation induces retinal apoptosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sawyer RA, Selhorse JB, Zimmerman LE. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 1976; 90:606–613.
Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration: Possible autoimmune disorder. Arch Ophthalmol 1983; 101:564–569.
Jacobson DM, Thirkill CE, Tipping SJ. A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 1990; 28:162–167.
Polans AS, Buczylko J, Crabb J et al. A photoreceptor calcium-binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol 1991; 112:981–989.
Ohguro H, Ogawa K, Nakagawa T. Both recoverin and hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1999; 40:82–89.
Adamus, G, Aptsiauri N, Guy J et al. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol 1996; 78:120–129.
Komgruth SE, Kalinke T, Grunwald GB et al. Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res 1986; 46:2588–2595.
Polans AS, Witkowska D, Haley TL et al. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA 1995; 92:9176–9180.
Maeda A, Ohguro H, Maeda T et al. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Cancer Res 2000; 60:1914–1920.
Maeda T, Maeda A, Maruyama I et al. Mechanisms of photoreceptor cell death in Cancer-associated retinopathy. Invest Ophthalmol Vis Sci 2001; 42:705–712.
Ohguro H, Ogawa K, MaedaTet al. Cancer-associated retinopathy induced by both antirecoverin and anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci 1999; 40:3160–3167.
Adamus G, Machnicki M, Seigel GM. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1997; 38:283–291.
Adamus G, Machnicki M, Elerding H et al. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun 1998; 11:523–533.
Frasson M, Sahel JA, Fabre M et al. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nature Med 1999; 5:1183–1187.
Bush RA, Kononen L, Machida S et al. The effect of calcium channel blocker diltiazem on photoreceptor degeneration in the rhodopsin Pro23His rat. Invest Ophthalmol Vis Sci 2000; 41:2697–2701.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ohguro, H., Nakazawa, M. (2002). Pathological Roles Of Recoverin In Cancer-Associated Retinopathy. In: Baehr, W., Palczewski, K. (eds) Photoreceptors and Calcium. Advances in Experimental Medicine and Biology, vol 514. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0121-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0121-3_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4933-4
Online ISBN: 978-1-4615-0121-3
eBook Packages: Springer Book Archive